Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
International journal of molecular sciences · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 1 institution in 2 countries.
Huma HameedUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.ORCID 0000-0002-8636-8644
Muhammad FarooqUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.ORCID 0000-0002-8771-3219
Céline VuillierUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.
Claire Piquet-PellorceUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.
Annaïg HamonUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.
Marie-Thérèse Dimanche-BoitrelUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.
Michel SamsonUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.
Jacques Le SeyecUniv Rennes, Inserm, EHESP, IRSET (Institut de Recherche en Santé, Environnement ET Travail)-UMR_S 1085, F-35000 Rennes, France.ORCID 0000-0002-1118-3311
Inserm · FR
Funding
Contrat de Plan Etat-Région InfectioFondation pour la Recherche Médicale DEQ20180339216Ligue Contre le Cancer Comités du Grand Ouest
6 · The paper itself
Abstract
Some life-threatening acute hepatitis originates from drug-induced liver injury (DILI). Carbon tetrachloride (CCl
Indexed as
Chemical and Drug Induced Liver InjuryChemical and Drug Induced Liver Injury, ChronicHepatitisAnimalsApoptosisCarbon TetrachlorideHepatocytesLiverMiceReceptor-Interacting Protein Serine-Threonine KinasesTumor Necrosis Factor-alphaCarbon TetrachlorideReceptor-Interacting Protein Serine-Threonine KinasesRipk1 protein, mouseTumor Necrosis Factor-alphaacute hepatitisapoptosiscarbon tetrachloridedrug-induced liver injuryreceptor-interacting protein kinase-1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl · full record | OpenQuestion